openPR Logo
Press release

PE INTERNATIONAL supports "Bayer Climate Check" - Bayer launches corproate-wide climate program

11-28-2007 01:12 PM CET | Energy & Environment

Press release from: PE INTERNATIONAL

PE INTERNATIONAL supports "Bayer Climate Check" - Bayer

Leverkusen/Leinfelden-Echterdingen, 28 November 2007. Bayer has launched a corporate-wide "Climate Program" to reduce its CO2 emissions in in-house production even further and develop new solutions for climate protection and preparations for climate change. One project is the "Bayer Climate Check" for production processes.

"One essential way of reaching the CO2 reduction targets we have set for ourselves is the 'Bayer Climate Check' developed by Bayer Technology Services", Werner Wenning, board chairman at Bayer AG, told some 100 international journalists.

For the first time, the "Bayer Climate Check" will not only be used to assess production systems, but also for the raw materials and energy used for production and the entire logistics chain up to the grounds of the plant.

A new key performance indicator called the "Climate Footprint" will be used to assess factors relative to the climate. In addition to established economic parameters, this Climate Footprint provides an ecological parameter as a basis for decisions related to production processes, investments, and technology projects.

Sustainability specialist PE International's "GaBi" software solution is being used toward this end as an intelligent, flexible model of data analysis and interpretation. In addition, PE International is providing database systems for chemical primary products, transport, and the composition of electricity in numerous countries.

"This unique system allows detrimental effects on the climate to be detected all along the value chain", explains Wolfram Scharnhorst, project manager at PE International. But the system also requires high-quality consulting based on sound scientific methods, which must be completely objective and verifiable.

As soon as the spring of 2008, the solution is to be certified for "Bayer Climate Check" by TÜV Süd, a global leader in climate protection reports.

By the end of 2009, Bayer plans to have systematically analyzed 100 production systems worldwide that are responsible for some 85 percent of the firm's greenhouse gas emissions in order to identify potential for emission reductions.

PE INTERNATIONAL GmbH
Claudia Meder
Hauptstrasse 111-113
70771 Leinfelden-Echterdingen, Germany
Phone: +49 - 711 34 18 17-17
Fax: +49 - 711 34 18 17-25
c.meder@pe-international.com
www.pe-international.com

About Bayer Technology Services:
Bayer Technology Services GmbH offers holistic solutions for the entire lifecycle of chemical-pharmaceutical systems -- from development to planning, construction, and process automation of current systems. The subsidiary of Bayer employs almost 2400 experts across the globe -- from its headquarters in Leverkusen, Germany and other locations in Germany to regional offices in Baytown, Texas; Antwerp, Belgium; Mexico City, and Shanghai. Some 380 million euros in revenue was posted in 2006.For further information on Bayer Technology Services, visit us on the Internet at www.bayertechnology.com.

On PE INTERNATIONAL GmbH:
Sustainability is the path towards corporate actions with a view to the future and a more livable environment. Since 1989, PE International has been supporting companies all over the world who want to go down this path consistently. Today, the company is a global leader in strategic consulting, software systems, and comprehensive services related to sustainability issues. The methods we use include, for instance, the implementation of management systems, the development of sustainability indicators, lifecycle analyses, ecology reports, carbon footprints, environmental product declarations, technological benchmarking, eco-efficiency analyses, energy efficiency, and emissions management.

PE International also offers two leading software solutions: GaBi for product sustainability and SoFi for corporate sustainability. More than 500 corporations and institutes worldwide trust the consulting services and software solutions of PE International, including such market and industry leaders as Alcan, Allianz, Bayer, DaimlerChrysler, Deutsche Post/DHL, Rockwool, Siemens, Toyota, ThyssenKrupp and Volkswagen. PE International has regional offices in Stuttgart, Vienna, Tokyo, Taipei, Perth, Boston, and Kuala Lumpur.
For further information on PE INTERNATIONAL and Carbon Footprints, visit us on the Internet at www.pe-international.com/consulting/carbon-footprint/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PE INTERNATIONAL supports "Bayer Climate Check" - Bayer launches corproate-wide climate program here

News-ID: 33063 • Views:

More Releases for Bayer

Regorafenib Market Analysis By Top Key Players - Bayer Pharmaceuticals, Beacon P …
The "Regorafenib Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Regorafenib Market, 2024-2031 Verified Market Research's most recent report, "Regorafenib Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the
Radiopharmaceuticals Market 2022 Sales Revenue - Bracco Imaging, Bayer, Mallinck …
Global Radiopharmaceuticals Market from 2022 to 2028 launched by MarketsandResearch.biz comprises a comprehensive market analysis that encompasses key aspects of the industry and defines current market dynamics in detail. It assesses growth patterns, magnitudes, and specific business developments under the current market scenario. The best statistical surveying and investigation performed with the advanced tools and techniques in this report. The study report shows a balanced presentation of statistical and theoretical
Point of Care Molecular Diagnostics Market Industry Analysis with Abaxis, Inc., …
The Point of Care Molecular Diagnostics Market is set to exceed USD 2.5 billion by 2024; according to a new research study published by Global Market Insights, Inc. Increasing awareness regarding pre-disease diagnosis along with growing incidence of infectious diseases will drive point of care molecular diagnostics market growth. Growing R&D focused on reducing time required for molecular tests will further propel industry growth. However, long product development time and
Companies Profiled in Point of Care Molecular Diagnostics Market are Abaxis, Inc …
Global Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth. Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which
Companies Profiled in Point of Care Molecular Diagnostics Market are Abaxis, Inc …
Global Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth. Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which
Drug Delivery Market 2018 | Johnson, Bayer
Report Summary The Global Drug Delivery Market Size is primarily driven by the increasing demand for technological advanced products that are used for drug delivery, and increased number of chronic diseases in the increasing number of geriatric population. Drug delivery is referred as drug administration in the human body through injections or various other devices. Drug delivery devices are used to inject the therapeutic substances in the body with the help of